Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors
=========================================================================================================================================================================================

* Jian-Guo Zhou
* Anna-Jasmina Donaubauer
* Benjamin Frey
* Ina Becker
* Sandra Rutzner
* Markus Eckstein
* Roger Sun
* Hu Ma
* Philipp Schubert
* Claudia Schweizer
* Rainer Fietkau
* Eric Deutsch
* Udo Gaipl
* Markus Hecht